ArticleScientific reports2025
Incidence, risk factors, and outcomes of respiratory related hospitalizations in older patients with COPD, asthma, and bronchiectasis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine learning-based cross-sectional exploration of depression-chronic pain associations in chronic respiratory disease patients.BMC geriatrics · 2026Observational
- Spider Venom-Derived Peptide Exhibits Dual Anti-Inflammatory and Antioxidative Activities in LPS-Stimulated BEAS-2B Cells.Antioxidants (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The increasing prevalence of chronic respiratory diseases among older adults significantly affects morbidity and mortality rates. Hospitalizations from exacerbations and acute respiratory infections (ARIs) pose a substantial burden on healthcare systems. This study aimed to estimate the nationwide incidence of such hospitalizations among older adults with chronic respiratory diseases, identify risk factors, and assess outcomes like intensive care needs and mortality. Utilizing data from the National Health Insurance Service senior cohort (2016-2017), we analyzed patients aged 60 and above diagnosed with chronic obstructive pulmonary disease, asthma, or bronchiectasis. We followed hospitalization rates over two years, employing Cox regression models to identify predictors for hospitalizations. Out of 117,793 patients, 16,024 (13.6%) patients had overlapping respiratory diseases with COPD, asthma and/or bronchiectasis. Of the total population, 9.6% were hospitalized due to exacerbations or ARIs, showing an incidence rate of 10.6 per 100 patient-years. Notably, patients with multiple respiratory diseases had hospitalization rates over 20%. Of the 24,186 hospitalizations, 6.5% necessitated intensive care, and 2.2% were fatal. Increased risk of hospitalization was associated with being 85 or older, having multiple respiratory conditions, and taking certain medications such as antipsychotics and anti-dementia drugs. This study reveals a notable rate of hospitalization due to exacerbations or ARIs among older adults with chronic respiratory diseases, with age, multiple conditions, and specific medications being major risk factors. The findings underscore the need for targeted preventive strategies and careful management of this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.